Bimatoprost/timolol

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Bimatoprost/timolol
Combination of
BimatoprostProstaglandin analogue
TimololBeta blocker
Clinical data
Trade namesGanfort
AHFS/Drugs.comUK Drug Information
Routes of
administration
Topical (eye drops)
ATC code
Legal status
Legal status
  • UK: POM (Prescription only) [1]
  • In general: ℞ (Prescription only)
Identifiers
KEGG

Bimatoprost/timolol, sold under the brand name Ganfort, is a medication for the treatment of open angle glaucoma or ocular hypertension.[1][2]

It was approved for use in the European Union in May 2006.[2]

References[edit]

  1. ^ a b "Ganfort 0.3 mg/ml + 5 mg/ml eye drops, solution - Summary of Product Characteristics (SmPC)". (emc). 20 February 2020. Retrieved 1 March 2020.
  2. ^ a b "Ganfort EPAR". European Medicines Agency (EMA). 26 February 2020. Retrieved 1 March 2020.

Further reading[edit]

External links[edit]